MedTrace Logo

Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients

NCT03613467 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2145

Last updated 2018-08-09

No results posted yet for this study

Summary

The study was designed to compare the safety and effectiveness of vedio-assisted thoracoscopic lobectomy with open lobectomy for patients with surgically resectable pathologic N2 non-small cell lung cancer

Conditions

Interventions

PROCEDURE

VATS lobectomy

Patients who received lobectomy by video-assisted thoracoscopic surgery

PROCEDURE

Thoracotomy lobectomy

Patients who received lobectomy by thoracotomy

Sponsors & Collaborators

  • LinkDoc Technology (Beijing) Co. Ltd.

    collaborator INDUSTRY

  • Tang-Du Hospital

    lead OTHER

Principal Investigators

  • Xiaofei Li, PhD · Tang-Du Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-04
Primary Completion
2018-07-04
Completion
2018-07-06

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03613467 on ClinicalTrials.gov